Table Of Content

Author Index for Volume 28 Note: Page numbers preceded by S indicate May/June supplement. A Goossens GA, 61 Ngo \. 173 Abdollahi M, 188 Goss LK, 183 Noetscher CM, 307 Ackroyd-Stolarz SA. 399 Alexander M, 8, 85, 148, 218, 240, H O 299 399 Hanberg A, 36 Olson AF, 118 Alrwarg JD, 307 Haves J, 321 Ortolano GA, 273 Angelbeck |I 1, 27 ) Hibbard JS, 194 Arney TD, 329 Hornsby S, 45 P Arnold F, 183 Houck D, 170 Patterson IV, 265 Art G, 314 Huddleston R, 170 Pieger-Mooney S, $7 B Proctor 3 170 J Bass L, 15 Q Bates DW, 321 Jacobs BR, 3' Beauman SS, 159 Jae ger R] 54 Q2u inn C, 393 Beets B, 45 Berkheimer C, 17 K R Berreth M, 237 Rabin K, 30 Kelley PJ], 329 Brent NJ, 251 Keohane CA, 321 Rothschild JM, 32 Brown K, 54 Khalilzadeh A, 188 Burke KG, 87 S Knight JA, 108 C Knue M, 30 Saniuk C, 321 Smith GG, 258 Kokotis K, 45, $22 Campbell SG, 399 Stas M, 6 Carrico RM, 183 L T Casey S, 45 Cox JA, 99 Lagoe RJ, 307 Trojanowski J, 399 Landis S, 170 D Lauts NM, 337 V De Wever I, 61 Vazin A, 188 Doellman D, 30 M Dohse L, 23 Vrebos M, 61 Martin S, 265 Du Pen A, 377 Masoorli 8, S18 W Matter K, 45 E Walsh G, 123 Earhart A, $13 Miller-Hoover S, 385 Walsh M, 231, 248 Mojtahedzadeh M, 188 Weiss AL, 54 F Murphy E, 265 Westbrook | JO, 99 Murphy S, 173 Frederic k x | ; Whiteford J, 170 N y G Gelfand, EW, 366 Najafi A, 188 Yost CC, 130 Vol. 28, No. 6, November/December 2005 Subject Index for Volume 28 were 2 supplements to Volume 28. The March/April supplement was produced by American Journalo f Nursing and is \ nm tne inde x Page numbers preceded by S$ indicate the May/June supplement. mmu ioglobulin Central venous catheters accessd evices for. See Vascular access nh, Megnesium devices innovations in, $7 function tests in, patients’ experience with, 61 peripherally inserted blood sampling through, in chil dren, 30 full-time specialist staff for, 45 lsorders, insertion of, nurse training in, $7 occlusion of, nurse training in, 173 hopathic arthritis, placement of, innovations in, $7 Chemotherapy, allerg! reactions in, 170 100d product ecukocyte reduc Children. Sec also Neonates Blood sampling, thre ipherally in isthma exact rb tions in, Magnesium sulfate for, 329 serted central catheter devices, blood sampling in, through periph in children. 30 erally inserted central catheter Bortezomib, for mult pl myeloma, 258 devices, 30 Bulimia ner osa lectrolyte imbalanceisn , juvenile idiopathic arthritis in, 385 outpatient management of, 118 hloride imbalances, in eating disorders, 118 hronic liver disease, liver function tests in, nd complementary therapy, 108 liver function tests in, 108 ombination povidone iodine-alcohol for transte se, increased, s of, 108 hemotherapy for, allergic reactiotno , mulations, 314 Anah« ver function tests for, 1O8 170 ommunity-wide infusion therapy programs, Anal; le idiopathic irthritis, proteasome inhibition for, 258 development and implementa Carboplatin, allergic reaction to, 170 tion of, 307 \nor sa, electrolyte imbalanceisn , Caregiver teaching, for home infusion Complementary therapy, liver function tests outpatient management of, 118 therapy, 99 in, 108 \ntd ormone, dehciency/excess of, 36 Catheter(s), omputerized patient data, privacy of, 251 \ un | resistance1,83 iccess devices for. See Vascular access Conhdentiality, of electronic patient data, 251 Antines tic therapy, devices Congestive heart failure central venous. See ¢ entral venous end-stage, home care for, 393 Ant catheters liver function tests in, 108 ition povidone tod/i ne-alcono} l, ] epidural, management of, 3 Continuing education credits. See CRNI intrathecal, management of, 377 Certification Examination ind ettectivenesosf , 194 peripheral intravenous, flushing of, Cost containment, $22 isopressin, dehciency/excess of, 36 frequency of, 399 CRNI® Certification Examination, review venile idiopathic, 385 plasticizers in, safety of, in neonates, 54 questions for, 68, 405, $33 Journal of Infusion Nursing jury, serun | g‘rYTo w: th h f¢ ac—to r cor Juvenile i. id20 iopathi| c arth| ritis, 23O8S5 dehydrogenase, increased, causes of, 108 or 1 992 cyte reduction, universal, 2/5 wiity issues, S18 function tests, 1O8 in eating disorders, 118 njury, acute, furosemide for, serum epsiidde rmal! | growtgrhow tl factor con centration after, 188 » h home ¢ ii n, 97993 Luteinizing hormone, deficiency/excess of, 3> 6 tunction tests in, 108 Hepatobiliary disease, liver function tests in, M 1O8 Macrophage activation syndrome, in juvenile Herbal remedies, liver function tests in, 108 idiopathic arthritis, 385 Home infusion therapy Magnesium sulfate, for asthma exacerba in end-stage heart tailure, 393 _ tions, 529 yatient/family teaching for, 99 Malnutrition, refeedi' ng syndrome in, 3_3 Hyperbilirubinemia, liv function tests in t ’ ‘ , Malpractice, nursing, $18 1O8 Medical records, electronic, privacy . , Hyyppeerrcchhlloorreemmi!a , inn eatinign g didsiosrodr ders, 11 4) Medicare reimb| ursement issues, $22 Hypernatremiai,n eating disorders, 118 Me Henle Hyperprolactinemia, 36 illergic reactiontso , 170, 265 Hypochloremia, in eating disorders, 118 intimicrobial resistance to, 183 Hypoder7m oclyskioss , 1223 hepatotoxic, liver function tests and, Editorials, 8, Hypokalemia, in eating disorders, 118 108 Educatior , ; Hyponatremia, in eating disorders, 118 Medication safety Hypoprolactinemia, 36 administration, March/April supplement I in ambulatory infusion setting, 170 smart infusion systems and, 321 IgG anaphylaxis, after [V immunoglobulin - symposiuomn , 5 infus-i on, 265 Meningitis, aseptic, after IV immunoglobulin Immunoglobulin. See Intravenous infusion, 265 ~ ae See eee immut ne vl amiilei Methicillin-resistant Staphylococcus aureus, ideriy, - hypode Oclysi Infants. See Chi, ldren; Neonates 183 Electrolyte imbalances ayting disoar S ; tic Bi ina Infusion Nurses Society Microintroducers. S7 avait Sie 2) 004) Finn ancial IR eport, 273, 27 Modified Seldinger technique, $ _— Cf hi. ef Executive Officer’s R)e pro rtr , 2) 40{ Multiple myeloma, 1b ortezomib 1 for, 25c8o Presidential Address, 248 yo State of the Society Report, 23 N necro: ti Infusion systems crotizing enterocolitis, neonatal, 13. 0 Epidermal log rowth. fa' ctor ' conc, entsrtarat ion, . . “:s mart, Negligence, by infusion nurse, $18 : furosemmiiddee inf, usion, fo ' Infusion , therapIy onatal abstinence syndrome, 15. 9 lliunngge in"j ury, 18* 8 community-wil Ge {c pwroougrraal ns for, onatal necrotizing enterocolitis, 130 Epidu' ral] cathe. ters, r management¢ of, 3 7 de¢ vel| opBmtne nt and iWu mpl>]e mentation } ae ee ee ee Epniidd urog9r ams, 33 77 of, J3 07 dj i-2-ethylhexylphthalate exposure in, cost containment in, $22 54 F home-administered New products and services, 72 , n ¢ 9 > 393 ? 242 Family te iching, for home infusior } >> in end stage heart failure, y7 282, 34 >, 409 Fl| uid management patient/family| teachingg for, 99 Nonalcoholic steatohepatitis, liver function hypodj ermoclysiisn , 123 , leag al issues 'i n, & $18 : tests in, 108 ; in refeeding syndrome, 337 Intrathecal catheters, management of, 5 Nurse education, for pe ripherally inserted Flushing,o f peripheral intravenous catheters, Intravenous immunoglobulin central catheters frequency of, 399 administration of, practice guidelines for insertion and management, $7 Follicle-stimulating hormone, deficiency for, 2) 65 for occlusion management and preven- excess of, 36 selectioonf , 366 tion, 173 Vol. 28, No. 6, November/December 2005 Nursing malpractice, $18 tassium imbalances, in eating disorders, Syndrome of inappropriate antidiuretic hor Nutritional support, refeeding syndrome 118 mone secretion, 36 ind, 33 Povidone iodine-alcohol formulations, 314 Precertification, infusion nurse’s role in, 23 ¥ O Privacy, of electronic patient data, 251 ) Terminal care, in-home, in congestive heart Occlusiot Prolactin, deficiency/excess of, 36 292 of peripherall ted tt : , failure, 393 peripherally inserted central Proteasome inhibitors, for multiple . _ Therape utic interventions, affecting vascular myeloma, 255 management and preventioonf , 173 . , , , , devices, $13 Prothrombin time, in hepatobiliary disease, Oxytocin, deficiency/excess of, 36 10 Thromboembolism, after [V immunoglobu O8 lin infusion2,6 5 P hyroid-stimulating hormone, deficiency/ex Paclitaxel, allergic reactiontos, 170 Q cess of, 36 Pain management, in juvenile idiopathic Quality of life, venous access ports and, 61 lranstusions, universal leukocyte reduction irthritis, 385 tor, 273 Pa) tient records, electronic, privacy of, 20541 |g Pat it/famuly teaching R. eteeding syndrome, 33 y U health literacy and, 15 , _ for home infusion therapy, 99 Rehydration, hypodermoclysis in, 123 Ultrasound guidance, for central | venous Pe=di atric pa es Soo ( ; ldren: Neonat Reimbursement issues, $22 cathheeteerr ppllaaccees ment, S7 Renal failure, after [V immunoglobulin inf , —_ P hera Ca" theter, athet S 1 nisio n. ’ ’ 265 —- UUvneiivteirss,a l in lejuuvkeonciyltee, irdeidoupcattihoinc, a2r7t3h ritis, r | of. freaue vy of. 399 385 ’ } opatti port ) ) ited S 8 Satety. See Medication satety V phera rted central cathete S State of the Science on Safe Medication Pees : Vascular access devices. See also \dministrat March/April sup , seendin hecmal , \ —_ Catheter(s t Bil, . plement diagnostic tools and therapeutic inter Seldinger technique. § aii =m t staff for. 45 ventions affecting$,13 t Se m epidermal! growth tactor concentra aia f. nurse training in. 173 : epidural, 5 , tion, after furosemide infusion, per < with, 61 innovatioinns, S nt of tr } te un miury [88 intrathecal, 37 Smart infusion systems, 321 itions in.S legal aspecoft, s$1 8 u uining in, S »0d n imbalances, itipnegt disorders, 118 patients’ experience with, 61 Stapl occus aureus, methicillin-resistant Pituitar orders, 3 Vasopressin, deficiency/excess of, 36 18 I t fety of leonat ’ Viral hepatitis, liver function tests in, 108 Port steatohepatitis, nonalcoholic, liver functior ; Viral meningitis, after IV immunoglobulin ’ st to. ind therap < ter t 1US ) t infusion2,6 5 ol ifte< SI yt nat : r function tests for, ° Vision loss, in juvenile idiopathic arthritis, | vd ’ ‘ arheter MS 85 ns S ] 4 iDt ; tratt il catheters. 3 r tu t t t n. 1()R ct tf. SIS p nam onatal abstinence W itiet ; F vith. 61 | ) Withdrawal symptoms, in neonates, 159 Journal of Infusion Nursing